Destiny Pharma (DEST)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

15.75p
   
  • Change Today:
    -0.50p
  • 52 Week High: 82.00
  • 52 Week Low: 15.50
  • Currency: UK Pounds
  • Shares Issued: 95.31m
  • Volume: 139,925
  • Market Cap: 15.01m
  • RiskGrade: 410

Destiny Pharma Overview

Destiny Pharma, a clinical stage biotechnology company focused on the development of novel anti-microbial drugs, which address the global problem of anti-microbial resistance (AMR).

1 Day Chart (17-05-2024)

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn n/a -314.5%
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue n/a 7.5
Pr/Book 1.6  
Latest F'cast
Revenue n/a n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

Destiny Pharma Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-19 n/a (5.52) (10.66)p n/a n/a n/a n/a 0.0%
31-Dec-20 n/a (6.48) (12.00)p n/a n/a n/a n/a 0.0%
31-Dec-21 n/a (6.27) (8.90)p n/a n/a n/a n/a 0.0%
31-Dec-22 n/a (7.71) (9.30)p n/a n/a n/a n/a 0.0%
31-Dec-23 n/a (6.45) (6.20)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Destiny Pharma Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-24 2.00 (6.29) (6.50)p n/a n/a n/a n/a 0.0%
31-Dec-25 n/a (8.00) (8.50)p n/a n/a n/a n/a 0.0%
31-Dec-26 n/a n/a n/a n/a n/a n/a n/a 0.0%

Copyright © 2024 FactSet Research Systems Inc. All rights reserved.

Destiny Pharma Company Announcements

Posting of Annual Report and Notice of AGM 09-May-2024 14:35 RNS
Full year results and review of strategic options 25-Apr-2024 07:00 RNS
Notice of Full Year Results 08-Apr-2024 07:00 RNS

Latest Destiny Pharma Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

Destiny Pharma Market Data

Currency UK Pounds
Share Price 15.75p
Change Today -0.50p
% Change -3.08 %
52 Week High 82.00
52 Week Low 15.50
Volume 139,925
Shares Issued 95.31m
Market Cap 15.01m
RiskGrade 410

Destiny Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
16.14% below the market average16.14% below the market average16.14% below the market average16.14% below the market average16.14% below the market average
5.88% below the sector average5.88% below the sector average5.88% below the sector average5.88% below the sector average5.88% below the sector average
Price Trend
88.19% below the market average88.19% below the market average88.19% below the market average88.19% below the market average88.19% below the market average
59.26% below the sector average59.26% below the sector average59.26% below the sector average59.26% below the sector average59.26% below the sector average
Income Not Available
Growth Not Available

What The Brokers Say

Strong Buy 0
Buy 1
Neutral 0
Sell 0
Strong Sell 0
Total 1
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Destiny Pharma Dividends

No dividends found

Trades for 17-May-2024

Time Volume / Share Price
17:07 2,000 @ 15.75p
16:18 9,000 @ 16.00p
15:24 6,193 @ 16.00p
14:26 15,598 @ 16.00p
14:09 43 @ 15.78p

Destiny Pharma Key Personnel

CEO Chris Tovey

Top of Page